Status:
NOT_YET_RECRUITING
Evaluation of the Safety and Performance of the Neocement® Inject P: A Prospective Observational Study in Dental Area
Lead Sponsor:
Bioceramed
Collaborating Sponsors:
Egas Moniz - Cooperativa de Ensino Superior, CRL
Conditions:
Bone Augmentation
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to collect real-world clinical data to gather information on the performance and safety of the Neocement® Inject P when used according to its intended purpose and current clinical appl...
Detailed Description
Neocement® Inject P is a synthetic bone substitute composed of calcium phosphates (tetracalcium phosphate and beta-tricalcium phosphate). It consists of two parts: a solid phase and an aqueous solutio...
Eligibility Criteria
Inclusion
- Adult males or females (age \> 18 years old);
- Patients who are able to sign an informed consent form (for data collection);
- Patients undergoing reconstructive dental surgery and indicated for the use of Neocement® Inject P;
Exclusion
- Patients who are unable to understand consent and the objectives of the study;
- Signs of local or systemic acute/ active or chronic infections;
- Metabolic affections;
- Severe degenerative diseases, conditions in which general bone grafting is not advisable;
- Implementation sites that allow product migration;
- Conditions which require structural support in the skeletal system;
- Conditions where the implantation site is unstable and not rigidly fixated;
- Sensibility to the implantable materials;
- Known hypersensitivity to the implant material.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT07179510
Start Date
October 1 2025
End Date
October 1 2027
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Egas Moniz School of Health and Science
Lisbon, Portugal